Today's Highlights
Premium
Monday, January 5, 2015: Outperforming and Positive Performing Picks
OUR OUTPERFORMING PICKS ON MONDAY 5/1/2015 ISIS: Closed at $68.17 UP $6.60 J&J is licensing three programs for autoimmune diseases from Isi...
P
Prohost Biotech
1 min read
3
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Agenus (AGEN)
BioCryst Pharmaceuticals (BCRX)
Calithera Biosciences (CALA)
Compugen (CGEN)
Gilead Sciences (GILD)
Halozyme Therapeutics (HALO)
Illumina (ILMN)
Incyte (INCY)
Ionis Pharmaceuticals Inc (IONS)
Kite Pharma - A Gilead Company
Receptos Inc (RCPT)
Regeneron Pharmaceuticals (REGN)
Theravance Biopharma (TBPH)
Theravance Inc (THRX)
Xoma (XOMA)
Comments (0)
Please sign in to join the discussion